rasagiline has been researched along with Hypertension in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salzman, P; Schwid, SR; White, WB | 1 |
| Adar, L; Goren, T; Sasson, N; Weiss, YM | 1 |
| Chen, JJ; Wilkinson, JR | 1 |
| Finberg, JP; Gillman, K | 1 |
| Eilam, R; Eliash, S; Shteter, N | 1 |
| Cohen, S; Eliash, S; Speiser, Z | 1 |
2 review(s) available for rasagiline and Hypertension
| Article | Year |
|---|---|
The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?
Topics: Antiparkinson Agents; Brain; Dietary Proteins; Dose-Response Relationship, Drug; Food-Drug Interactions; Humans; Hypertension; Indans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Safety; Risk Assessment; Risk Factors; Treatment Outcome; Tyramine | 2012 |
Selective inhibitors of monoamine oxidase type B and the "cheese effect".
Topics: Animals; Cheese; Humans; Hypertension; Indans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline | 2011 |
2 trial(s) available for rasagiline and Hypertension
| Article | Year |
|---|---|
Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease.
Topics: Aged; Antihypertensive Agents; Antiparkinson Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Food; Humans; Hypertension; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Postprandial Period; Supine Position; Telephone; Tyramine | 2008 |
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Topics: Adult; Aged; Algorithms; Contraindications; Diet; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Humans; Hypertension; Indans; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tyramine; United States | 2010 |
2 other study(ies) available for rasagiline and Hypertension
| Article | Year |
|---|---|
Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Indans; Male; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred SHR; Rats, Wistar; Third Ventricle; Treatment Outcome; Vasopressins | 2005 |
Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Indans; Male; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Rats; Rats, Inbred SHR; Sodium Chloride; Stereoisomerism; Stroke; Survival Rate; Treatment Outcome | 2001 |